Cyanide antidote launched

Cyanokit is an injectable preparation of hydroxocobalamin (vitamin B12) indicated for the treatment of known or suspected cyanide poisoning.

Hydroxocobalamin has a favourable safety profile in patients who have not been poisoned, making Cyanokit a useful option when cyanide exposure is unproven.
Hydroxocobalamin has a favourable safety profile in patients who have not been poisoned, making Cyanokit a useful option when cyanide exposure is unproven.

Cyanokit must be used alongside adequate supportive measures, including maintenance of airway patency, oxygen therapy, hydration, cardiovascular support and management of seizures.

Cyanide has a large number of industrial applications; poisoning with this substance typically occurs as a result of smoke inhalation or occupational exposure.

Hydroxocobalamin reacts with cyanide to form cyanocobalamin, which is eliminated in the urine.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New guidance for minimising psychological impact of COVID-19 pandemic in primary care patients
Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

MIMS launches Respiratory and Allergy Learning webinars

MIMS launches Respiratory and Allergy Learning webinars

Join us for the 2020 Respiratory and Allergy Learning...